tiprankstipranks
Tyra Bioscience (TYRA)
NASDAQ:TYRA
US Market

Tyra Bioscience (TYRA) Income Statement

Compare
122 Followers

Tyra Bioscience Income Statement

Last quarter (Q4 2025), Tyra Bioscience's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Tyra Bioscience's net income was $-33.83M. See Tyra Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -546.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 132.76M$ 104.18M$ 79.94M$ 58.93M$ 26.29M
Depreciation and Amortization
$ 546.00K$ 519.00K$ 357.00K$ 296.00K$ 140.00K
EBITDA
$ -119.40M$ -103.66M$ -79.59M$ -58.63M$ -26.15M
Operating Income
$ -132.76M$ -104.18M$ -79.94M$ -58.93M$ -26.29M
Other Income/Expenses
$ 12.81M$ 17.70M$ 10.81M$ 3.60M$ -6.00K
Pretax Income
$ -119.95M$ -86.48M$ -69.13M$ -55.33M$ -26.29M
Net Income
$ -119.95M$ -86.48M$ -69.13M$ -55.33M$ -26.29M
Per Share Metrics
Basic EPS
$ -2.01$ -1.51$ -1.62$ -1.23$ -0.63
Diluted EPS
$ -2.01$ -1.51$ -1.62$ -1.23$ -0.63
Weighted Average Shares Outstanding
59.60M 57.22M 42.70M 41.88M 41.44M
Weighted Average Shares Outstanding (Diluted)
59.60M 57.22M 42.70M 41.88M 41.44M
Currency in USD

Tyra Bioscience Earnings and Revenue History